Taiwan · Delayed Price · Currency is TWD Orient EuroPharma Statistics
Total Valuation
TPEX:4120 has a market cap or net worth of TWD 3.99 billion. The enterprise value is 6.98 billion.
| Market Cap | 3.99B |
| Enterprise Value | 6.98B |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | Jul 20, 2026 |
Share Statistics
TPEX:4120 has 86.75 million shares outstanding.
| Current Share Class | 86.75M |
| Shares Outstanding | 86.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.47% |
| Owned by Institutions (%) | 0.29% |
| Float | 31.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.86 |
| PB Ratio | 0.63 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.56.
| Current Ratio | 1.16 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.25 |
| Interest Coverage | -5.31 |
Financial Efficiency
Return on equity (ROE) is -7.15% and return on invested capital (ROIC) is -4.24%.
| Return on Equity (ROE) | -7.15% |
| Return on Assets (ROA) | -1.82% |
| Return on Invested Capital (ROIC) | -4.24% |
| Return on Capital Employed (ROCE) | -4.22% |
| Weighted Average Cost of Capital (WACC) | 3.18% |
| Revenue Per Employee | 13.72M |
| Profits Per Employee | -1.70M |
| Employee Count | 339 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.90 |
Taxes
In the past 12 months, TPEX:4120 has paid 157.18 million in taxes.
| Income Tax | 157.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.81% in the last 52 weeks. The beta is 0.08, so TPEX:4120's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -14.81% |
| 50-Day Moving Average | 47.22 |
| 200-Day Moving Average | 45.88 |
| Relative Strength Index (RSI) | 36.55 |
| Average Volume (20 Days) | 24,018 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4120 had revenue of TWD 4.65 billion and -575.93 million in losses. Loss per share was -6.64.
| Revenue | 4.65B |
| Gross Profit | 2.27B |
| Operating Income | -349.14M |
| Pretax Income | -315.14M |
| Net Income | -575.93M |
| EBITDA | -192.10M |
| EBIT | -349.14M |
| Loss Per Share | -6.64 |
Balance Sheet
The company has 1.64 billion in cash and 3.53 billion in debt, with a net cash position of -1.88 billion or -21.70 per share.
| Cash & Cash Equivalents | 1.64B |
| Total Debt | 3.53B |
| Net Cash | -1.88B |
| Net Cash Per Share | -21.70 |
| Equity (Book Value) | 6.34B |
| Book Value Per Share | 60.28 |
| Working Capital | 555.81M |
Cash Flow
In the last 12 months, operating cash flow was -602.50 million and capital expenditures -227.11 million, giving a free cash flow of -829.61 million.
| Operating Cash Flow | -602.50M |
| Capital Expenditures | -227.11M |
| Depreciation & Amortization | 157.03M |
| Net Borrowing | -8.34M |
| Free Cash Flow | -829.61M |
| FCF Per Share | -9.56 |
Margins
Gross margin is 48.77%, with operating and profit margins of -7.50% and -12.38%.
| Gross Margin | 48.77% |
| Operating Margin | -7.50% |
| Pretax Margin | -6.77% |
| Profit Margin | -12.38% |
| EBITDA Margin | -4.13% |
| EBIT Margin | -7.50% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 8.75%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 8.75% |
| Dividend Growth (YoY) | 300.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 8.75% |
| Earnings Yield | -14.43% |
| FCF Yield | -20.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2010. It was a forward split with a ratio of 1.16.
| Last Split Date | Jul 28, 2010 |
| Split Type | Forward |
| Split Ratio | 1.16 |
Scores
TPEX:4120 has an Altman Z-Score of 1.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.2 |
| Piotroski F-Score | 3 |